Bibliographic Details
| Title: |
Modeling the impact of the 13-valent pneumococcal conjugate vaccine serotype catch-up program using United States claims data. |
| Authors: |
Strutton DR; Vaccines Market Access and Outcomes Research Specialty Care Business Unit, Pfizer Inc, 500 Arcola Road, Dock D, COL-D4555, Collegeville, PA 19426-3930, USA., Farkouh RA, Rubin JL, McGarry LJ, Loiacono PM, Klugman KP, Pelton SI, Gilmore KE, Weinstein MC |
| Source: |
BMC infectious diseases [BMC Infect Dis] 2012 Aug 03; Vol. 12, pp. 175. Date of Electronic Publication: 2012 Aug 03. |
| Publication Type: |
Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: |
Publisher: BioMed Central Country of Publication: England NLM ID: 100968551 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2334 (Electronic) Linking ISSN: 14712334 NLM ISO Abbreviation: BMC Infect Dis Subsets: MEDLINE |
| Database: |
MEDLINE Ultimate |
